COCHRANE AIRWAYS GROUP abstracts

COCHRANE AIRWAYS GROUP

Abstracts of Cochrane Reviews

The Cochrane Library Issue 3, 2003

The full text of these reviews and protocols is available in The Cochrane Library

indicates the review is new in the current release of the Library.
indicates the review has been substantially amended since the last issue of the Library.

Note: 'Protocols' are the introduction, objectives, materials and methods for reviews currently being prepared and do not therefore have abstracts

What's new in this issue

Search abstracts

Browse by Review Group

Browse alphabetical list of titles

Reviews

Protocols

Aerosolized magnesium sulfate for acute asthma (Cochrane Protocol)
Almitrine for chronic obstructive pulmonary disease (Cochrane Protocol)
Anti-cholinergic therapy for acute asthma in children (Cochrane Protocol)
Anti-leukotrienes versus long-acting beta2-agonists as add-on therapy to inhaled corticosteroids for chronic asthma (Cochrane Protocol)
Antibiotics for chronic suppurative lung disease in children (Cochrane Protocol)
Anticholinergic agents for chronic asthma in adults (Cochrane Protocol)
Anticholinergic bronchodilators versus beta2-adrenoceptor agonists for stable chronic obstructive pulmonary disease (Cochrane Protocol)
Azathioprine as an oral corticosteroid sparing agent for asthma (Cochrane Protocol)
Beta2-receptor polymorphism for improving long-term beta-agonist efficacy in asthma (Cochrane Protocol)
Breast feeding and development of childhood wheeze (Cochrane Protocol)
Chloroquine as an oral corticosteroid sparing agent for asthma (Cochrane Protocol)
Colchicine as an oral corticosteroid sparing agent for asthma (Cochrane Protocol)
Combined corticosteroid and longacting bronchodilator in one inhaler for chronic asthma (Cochrane Protocol)
Combined corticosteroid and longacting bronchodilator in one inhaler for chronic obstructive pulmonary disease (Cochrane Protocol)
Combined corticosteroid and shortacting bronchodilator in one inhaler for chronic obstructive pulmonary disease (Cochrane Protocol)
Compliance with continuous positive airway pressure for obstructive sleep apnoea (Cochrane Protocol)
Continuous versus intermittent beta-agonists for acute asthma in the emergency department (Cochrane Protocol)
Cyclophosphamide for interstitial lung disease (Cochrane Protocol)
Education interventions for adults who attend the emergency room for acute asthma (Cochrane Protocol)
Educational interventions for asthma in adults (Cochrane Protocol)
Exposure to nitrogen dioxide for assessing allergen responsiveness in asthma (Cochrane Protocol)
Flunisolide for chronic asthma (Cochrane Protocol)
High versus low initial dose of inhaled corticosteroid for chronic asthma in adults and children (Cochrane Protocol)
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Protocol)
Humidification of inspired air in exercise-induced asthma (Cochrane Protocol)
Hydrotherapy for asthma (Cochrane Protocol)
Inhaled anti-cholinergics for prolonged non-specific cough in children (Cochrane Protocol)
Inhaled beta-2 agonists for treating non-specific chronic cough in children (Cochrane Protocol)
Inhaled beta-agonist and anticholinergic agents for emergency management of asthma in adults (Cochrane Protocol)
Inhaled corticosteroid prophylaxis for exercise induced bronchoconstriction (Cochrane Protocol)
Inhaled corticosteroids for stable chronic obstructive pulmonary disease (Cochrane Protocol)
Inhaled corticosteroids for treating non-specific chronic cough in children (Cochrane Protocol)
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma (Cochrane Protocol)
Inhaled ipratropium bromide for stable chronic obstructive pulmonary disease (Cochrane Protocol)
Inhaled long-acting beta-2 agonists and inhaled corticosteroids versus inhaled corticosteroids alone for chronic asthma in children and adults (Cochrane Protocol)
Inhaled long acting beta agonists for stable chronic asthma (Cochrane Protocol)
Inhaled nedocromil sodium for chronic asthma in children (Cochrane Protocol)
Inhaled tiotropium for stable chronic obstructive pulmonary disease (Cochrane Protocol)
Inhaled triamcinolone for chronic asthma (Cochrane Protocol)
Inspiratory muscle training for asthma (Cochrane Protocol)
Inspiratory muscle training for chronic obstructive pulmonary disease (Cochrane Protocol)
Interventions for improving asthma care in ethnic minorities (Cochrane Protocol)
Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis (Cochrane Protocol)
Intravenous immunoglobulin as a corticosteroid sparing agent for chronic asthma (Cochrane Protocol)
Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children (Cochrane Protocol)
Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction (Cochrane Protocol)
Mometasone for asthma in adults and children (Cochrane Protocol)
Monosodium glutamate avoidance for chronic asthma in adults and children (Cochrane Protocol)
Nebulisers versus all hand-held inhalers to deliver bronchodilators in chronic obstructive pulmonary disease (Cochrane Protocol)
Nebulisers versus hand-held inhalers to deliver beta-2 agonist bronchodilator drugs in non-acute asthma (Cochrane Protocol)
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma (Cochrane Protocol)
Non-selective beta agonists versus beta-2-agonists for acute asthma (Cochrane Protocol)
Oral prostheses for sleep apnoea (Cochrane Protocol)
Oral theophylline for stable asthma in adults (Cochrane Protocol)
Oral xanthines for maintenance treatment of childhood asthma (Cochrane Protocol)
Oxygen therapy for obstructive sleep apnea (Cochrane Protocol)
Oxygen versus air for nebulising beta-agonist bronchodilators in acute asthma (Cochrane Protocol)
Phosphodiasterase III inhibitors for chronic asthma (Cochrane Protocol)
Phosphodiasterase IV inhibitors for chronic asthma (Cochrane Protocol)
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease (Cochrane Protocol)
Pressure support ventilation following acute ventilatory failure in chronic obstructive pulmonary disease (Cochrane Protocol)
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver corticosteroids for non-acute asthma (Cochrane Protocol)
Prolonged high-dose antibiotics for purulent bronchiectasis (Cochrane Protocol)
Psychotherapeutic interventions for adults with asthma (Cochrane Protocol)
Psychotherapeutic interventions for children with asthma (Cochrane Protocol)
Red sage root for cor pulmonale (Cochrane Protocol)
Selenium supplementation for asthma (Cochrane Protocol)
Short acting beta 2 agonists for exercise induced asthma (Cochrane Protocol)
Short term ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Protocol)
Sildenafil for pulmonary hypertension (Cochrane Protocol)
Single inhalers containing corticosteroid and long-acting bronchodilator for chronic asthma in adults and children (Cochrane Protocol)
Systemic corticosteroids for stable chronic obstructive pulmonary disease (Cochrane Protocol)
Thrombolytic therapy for pulmonary embolism (Cochrane Protocol)
Vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease (Cochrane Protocol)

The Cochrane Library is designed and produced by Update Software Ltd.

Update Software Ltd, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK
(Tel:+44 1865 513902; Fax:+44 1865 516918)